Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis
Stephen J Clarke, Sonia Yip, Chris Brown, Guy A van Hazel, David T Ransom, David Goldstein, G Mark Jeffrey, Niall C Tebbutt, Martin Buck, Raymond M Lowenthal, Amy Boland, Val Gebski, John Zalcberg, R John Simes
European Journal of Cancer | ELSEVIER SCI LTD | Published : 2011
AGITG was the sponsor responsible for undertaking the DaVinci trial, and the NHMRC Clinical Trials Centre was the coordinating centre responsible for performing the trial under the auspices of AGITG. The trial was supported by an educational grant from Pfizer Australia Pty Ltd.